Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

Pfizer is ending the commercialization of Beqvez, its hemophilia B gene therapy, according to multiple media reports. It marks an abrupt end for the gene therapy for the rare, inherited bleeding disorder. Pfizer gained ...

Feb 21, 2025 - 13:26

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

Pfizer is ending the commercialization of Beqvez, its hemophilia B gene therapy, according to multiple media reports. It marks an abrupt end for the gene therapy for the rare, inherited bleeding disorder. Pfizer gained ...